文献速递慢性肾脏病

自我报告用药依从性与CKD进展的关联

Self-reported Medication Adherence and CKD Progression.
PubMed 文献 · Kidney Int Rep · 2018-02-02

本研究基于CRIC队列3305例轻中度CKD成人,用3个问题评估基线自我报告用药依从性并分为高、中、低三组。中位随访6年,低依从组较高依从组CKD进展风险升高(HR=1.27,95%CI 1.05–1.54),全因死亡风险相似但未达统计学显著性。

要点

  • 低自我报告用药依从性与CKD进展风险升高独立相关。
  • 低依从性与全因死亡风险升高无统计学显著性。
  • 用药依从性可作为CKD进展风险分层参考。

核心结论

  • 基线自我报告低用药依从性与CKD进展风险升高相关。
  • 低依从性与全因死亡风险的关联未达统计学显著性。

研究设计与样本

  • 前瞻性观察性研究,纳入CRIC研究中3305例轻中度CKD成人。
  • 用3个问题评估基线自我报告用药依从性,分为高、中、低三组。
  • 中位随访6年,用多变量Cox比例风险模型分析CKD进展和全因死亡。

主要发现

  • 68%为高依从,17%为中依从,15%为低依从。
  • 随访期间发生969例CKD进展事件和675例死亡。
  • 调整社会人口学、临床因素、心血管药物、药物种类数和抑郁症状后,低依从组较高依从组CKD进展风险升高(HR=1.27,95%CI 1.05–1.54)。
  • 低依从组较高依从组全因死亡风险相似(HR=1.14,95%CI 0.88–1.47),未达统计学显著性。

临床怎么用

  • 在CKD管理中可评估自我报告用药依从性,低依从者或需加强随访与干预。
  • 低依从性可作为CKD进展风险升高的提示因素之一。

局限性

  • 用药依从性为基线自我报告,可能存在测量偏差。
  • 研究为观察性设计,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In the general population, medication nonadherence contributes to poorer outcomes. However, little is known about medication adherence among adults with chronic kidney disease (CKD). We evaluated the association of self-reported medication adherence with CKD progression and all-cause death in patients with CKD. METHODS: In this prospective observational study of 3305 adults with mild-to-moderate CKD enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study, the baseline self-reported medication adherence was assessed by responses to 3 questions and categorized as high, medium, and low. CKD progression (50% decline in eGFR or incident end-stage renal disease) and all-cause death were measured using multivariable Cox proportional hazards. RESULTS: Of the patients, 68% were categorized as high adherence, 17% medium adherence, and 15% low adherence. Over a median follow-up of 6 years, there were 969 CKD progression events and 675 deaths. Compared with the high-adherence group, the low-adherence group experienced increased risk for CKD progression (hazard ratio = 1.27, 95% confidence interval = 1.05, 1.54) after adjustment for sociodemographic and clinical factors, cardiovascular medications, number of medication types, and depressive symptoms. A similar association existed between low adherence and all-cause death, but did not reach standard statistical significance (hazard ratio = 1.14 95% confidence interval = 0.88, 1.47). CONCLUSION: Baseline self-reported low medication adherence was associated with an increased risk for CKD progression. Future work is needed to better understand the mechanisms underlying this association and to develop interventions to improve adherence.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Cedillo-Couvert EA, Ricardo AC, Chen J, et al. Self-reported Medication Adherence and CKD Progression. Kidney Int Rep. 2018. PMID: 29854972. doi:10.1016/j.ekir.2018.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。